Aster DM Healthcare Limited — Investor Meet, 14-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates
14-11-2025 | 02:13 pm
14-11-2025 | 02:13 pm
Q2 FY26 saw Aster DM's revenue grow 10% YoY to INR 1,197 Cr, with Operating EBITDA up 13% to INR 263 Cr (22% margin). Normalised PAT rose 14% to INR 110 Cr. The Kerala cluster achieved record quarterly revenue of INR 620 Cr, signaling strong recovery with 69% occupancy. QCIL (proforma) revenue grew 15.1% YoY to INR 1,193 Cr, with EBITDA up 21.6% to INR 287 Cr (24.1% margin). The merger with Quality Care India is progressing, expected to create a 38-hospital network with over 10,360 beds. Management is confident in sustainable growth, driven by specialty mix and cost efficiencies, expanding capacity by 2,300+ beds.
No comments yet. Be the first to comment!
